1. India Stocks

  2. •

    Industrials

  3. •

    Manufacturing - Textiles
Trident Texofab Limited

Trident Texofab Limited

TTFL.BO
Trident Texofab LimitedIN flagBombay Stock Exchange
33.81
INR
-0.38
- -
507.01MMarket Cap

Total Valuation

Trident Texofab Limited carries a market capitalization of 507.01M, placing it among publicly traded companies globally. Its enterprise value stands at 1.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap507.01M
Enterprise Value1.04B

Share Statistics

Trident Texofab Limited currently has 15.00M shares outstanding.

Shares Outstanding15.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Trident Texofab Limited trades at a trailing price-to-earnings ratio of 95.68. The price-to-sales ratio is 0.57, and the price-to-book ratio stands at 4.49.

PE Ratio95.68
PS Ratio0.57
PB Ratio4.49
P/TBV Ratio1.21
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Trident Texofab Limited trades at an EV/EBITDA multiple of 29.73 and an EV/FCF ratio of 64.64. The EV/Sales ratio of 0.88 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.73 provides insight into valuation relative to core operating earnings.

EV / Sales0.88
EV / EBITDA29.73
EV / EBIT29.73
EV / FCF64.64

Financial Position

Trident Texofab Limited maintains a current ratio of 2.11, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 65.95, indicating elevated leverage, while an interest coverage ratio of 1.19 demonstrates limited ability to service its debt obligations.

Current Ratio2.11
Quick Ratio0.00
Debt / Equity65.95
Debt / EBITDA10.48
Interest Coverage1.19

Financial Efficiency

Trident Texofab Limited posts a return on equity of 3.88 and a return on invested capital of 2.25.

Return on Equity (ROE)3.88
Return on Assets (ROA)0.67
Return on Invested Capital (ROIC)2.25
Return on Capital Employed (ROCE)4.51
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.76

Taxes

Over the trailing twelve months, Trident Texofab Limited has paid 5.78M in income taxes, reflecting an effective tax rate of 45.08.

Income Tax5.78M
Effective Tax Rate45.08

Stock Price Statistics

Trident Texofab Limited's stock has declined approximately -84.34722% over the past 52 weeks. The 50-day moving average sits at 42.69, while the 200-day moving average is 176.62.

Beta (5Y)N/A
52-Week Price Change-84.34722%
50-Day Moving Average42.69
200-Day Moving Average176.62
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Trident Texofab Limited generated 1.18B in revenue and converted that into 7.04M in net income, yielding earnings per share of 0.46. EBITDA reached 34.96M, while operating income came in at 34.96M.

Revenue1.18B
Gross Profit127.80M
Operating Income34.96M
Pretax Income12.82M
Net Income7.04M
EBITDA34.96M
EBIT34.96M
Earnings Per Share (EPS)0.46

Balance Sheet

Trident Texofab Limited holds 1.12M in cash and equivalents against 366.59M in total debt, resulting in a net debt position of 335.41M. Total book value stands at 149.96M, with working capital of 412.02M providing operational flexibility.

Cash & Cash Equivalents1.12M
Total Debt366.59M
Net Debt335.41M
Equity (Book Value)149.96M
Book Value Per Share10.20
Working Capital412.02M

Margins

Trident Texofab Limited operates with a gross margin of 10.83, reflecting its pricing power and cost economics. The operating margin of 2.96 and net profit margin of 0.60 provide insight into operational efficiency.

Gross Margin10.83
Operating Margin2.96
Pretax Margin1.09
Profit Margin0.60
EBITDA Margin2.96

Stock Splits

Trident Texofab Limited's most recent stock split took place on August 11, 2020 with a 5:12 split ratio.

Last Split Date8/11/2020
Split Ratio5:12

Scores

Trident Texofab Limited posts an Altman Z-Score of 2.34, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.34